The CD31 molecule: a possible neuroprotective agent in acute ischemic stroke?

Thrombosis Journal

Table 2 Correlation analysis

		CD31	NIHSS pre	NIHSS post	ΔNIHSS	mRS 90 days
CD31	Correlation coefficient (r) Significance (p) n	1.00	0.035	−0.151	0.371	−0.095
		—	0.767	0.201	0.001	0.593
		79	75	73	72	34

Correlation analysis of clinical outcome parameters and the amount of CD31⁺ cells. (Bold type of the ΔNIHSS values indicate significance)

ISSN: 1477-9560